Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.
Press releases published on August 11, 2025
Flexible Spinal Implants Market Size Will Attain USD 9.21 Billion by 2032 Growing at 9% CAGR - Exclusive Report by Zion Market Research | Global Flexible Spinal Implants Market Size, Share, Trends Analysis Report
GlobeNewswire
·
August 11, 2025
NEW YORK, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Flexible Spinal Implants Market By Type (Hooks, Rods, Plates, Pedicle Screws, Cages, and Others), By Application (Lumbar, Thoracic, Artificial …
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
GlobeNewswire
·
August 11, 2025
Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five years. WARREN, N.J., Aug. 11, 2025 ( …
Gastric Cancer Market on Growth Trajectory: Novel Therapies Drive Momentum Through 2034 | DelveInsight
GlobeNewswire
·
August 11, 2025
New York, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gastric Cancer Market on Growth Trajectory: Novel Therapies Drive Momentum Through 2034 | DelveInsight The outlook for the gastric cancer treatment market appears favorable, fueled by progress in targeted …
BHIANT Quarterly Update: North Texas Bio Innovation Gains Momentum with Workforce Development and Industry Collaboration
GlobeNewswire
·
August 11, 2025
DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT, the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North Texas’ position as a rising life sciences powerhouse. With …
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
GlobeNewswire
·
August 11, 2025
Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient accessibility. WARREN, N.J., Aug. 11, …
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2025 Financial Results on August 14, 2025
GlobeNewswire
·
August 11, 2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the second quarter ended …
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
GlobeNewswire
·
August 11, 2025
CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI Innovators Award. These six distinguished leaders have been recognized for their outstanding contributions to advancing …
Rising Cyber Threats to Brazil’s Health Sector Highlighted in New Health-ISAC Report
GlobeNewswire
·
August 11, 2025
ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Health-ISAC, a non-profit organization dedicated to ensuring resilience in the global health sector, has released a new report warning of intensifying threats to Brazil’s health system and urging stronger …
Aumento das Ameaças Cibernéticas ao Setor de Saúde do Brasil é Destacado em Novo Relatório da Health-ISAC
GlobeNewswire
·
August 11, 2025
ORLANDO, Flórida, Aug. 11, 2025 (GLOBE NEWSWIRE) -- A Health-ISAC, uma organização sem fins lucrativos dedicada a garantir a resiliência do setor de saúde global, publicou um novo relatório que alerta sobre a intensificação das ameaças ao sistema de saúde …
TOMI Environmental Solutions Secures Order from ARES Distribution
GlobeNewswire
·
August 11, 2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has received a significant order from ARES …
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
GlobeNewswire
·
August 11, 2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic …
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
GlobeNewswire
·
August 11, 2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce today …
The SBB Research Group Foundation Sponsors Live4Lali
GlobeNewswire
·
August 11, 2025
CHICAGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Live4Lali collaborated in a volunteer initiative alongside the SBB Research Group Foundation, which partners with local nonprofits through its Champion A Charity Program. On June 29, 2025, a volunteer from the …
Sonnet Releases Virtual Investor "What This Means" Segment
GlobeNewswire
·
August 11, 2025
- Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of its clinical study of patients with platinum-resistant ovarian cancer (PROC) (SB221) - Watch the "What This Means" video here PRINCETON, N.J., Aug. 11, …
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
GlobeNewswire
·
August 11, 2025
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter …
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
GlobeNewswire
·
August 11, 2025
Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a …
Global Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.
GlobeNewswire
·
August 11, 2025
Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The global cancer vaccines market is on track to nearly double over the next decade, climbing from USD 9.84 billion in 2024 to USD 15.00 billion by 2032 at a CAGR of 5.4%, according to MarketsandMarkets™. …
Nationally Recognized Health Economist Austin Frakt to Lead Joint Commission Research Center
GlobeNewswire
·
August 11, 2025
OAKBROOK TERRACE, Illinois, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Joint Commission today announced a significant step forward in its approach to accelerating insights into quality, safety, and burden reduction. Austin Frakt, PhD, a nationally recognized health …
Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025
GlobeNewswire
·
August 11, 2025
Presentation will be the interim data from the Phase 2 study of istaroxime in SEISMiC C - Cardiogenic Shock SCAI Stage C Cardiogenic shock SCAI Stage C has an in hospital mortality rate of 20-30% Istaroxime interim data was consistent with the profile seen …
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
GlobeNewswire
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …